Swiss National Bank Pulse Biosciences, Inc. Transaction History
Swiss National Bank
- $150 Billion
- Q3 2024
A detailed history of Swiss National Bank transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Swiss National Bank holds 35,900 shares of PLSE stock, worth $652,662. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,900Holding current value
$652,662% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PLSE
# of Institutions
76Shares Held
5.4MCall Options Held
139KPut Options Held
84.2K-
Black Rock Inc. New York, NY1.15MShares$20.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA996KShares$18.1 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC786KShares$14.3 Million0.0% of portfolio
-
State Street Corp Boston, MA461KShares$8.39 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA457KShares$8.31 Million0.0% of portfolio
About Pulse Biosciences, Inc.
- Ticker PLSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,125,900
- Market Cap $675M
- Description
- Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...